FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 8/19/2026

1. MRNA
2. KLAR
3. KEYS
4. PANW
5. MRK

6. HD
7. SPY
8. DVLT
9. MRCY
10. LOW

August 10, 2016 12:50 PM EDT

Price: $0.31 +3.33%

Overall Analyst Rating:
SELL (= Flat)

Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:

FDA, Insiders' Blog

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!